HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT United States of America flag

HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT, published by HL7 International Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/standardhealth/fsh-ae/ and changes regularly. See the Directory of published versions

Example AdverseEvent: ctc-adverse-event-example-3

Generated Narrative: AdverseEvent

Resource AdverseEvent "ctc-adverse-event-example-3"

Profile: CTC Adverse Event

CTC Adverse Event Grade: Severe Adverse Event (CTCAE Grade Code System#3)

Adverse Event Seriousness Outcome: Adverse Event associated with Hopitalization (NCI Thesaurus#C83052)

Adverse Event Expectation: Expected Adverse Event (NCI Thesaurus#C41333)

Adverse Event Resolved Date: 2021-06-22

Adverse Event Participant

url

function

value: authenticator (ParticipationType#AUTHEN)

url

actor

value: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"

actuality: actual

event: DHN IV given (MedDRA Am Engl#10012174 "Dehydration")

subject: Patient/PatientPersona2 " C."

date: 2021-06-21

seriousness: Serious Adverse Event (NCI Thesaurus#C41335)

outcome: Resolved (AdverseEventOutcome#resolved)

recorder: Practitioner/PractitionerExample1 " ANYDOC"

suspectEntity

instance:

code: gefitinib 250 MG Oral Tablet (RxNorm#349472)

Causalities

-Assessment
*Adverse Event Probably Related to Intervention (NCI Thesaurus#C53259)

Generated Narrative: Medication #medication-example-1

code: gefitinib 250 MG Oral Tablet (RxNorm#349472)